David Serreze's latest paper, published in the Journal of Immunology, was named a Top Read in the July issue for its findings regarding a protective mechanism against type 1 diabetes in an important mouse model for the disease.
Ron Korstanje at JAX is searching for genetic clues to slowing the progress of end-stage renal disease in patients with Alport syndrome and other kidney diseases.
JDRF has announced the launch of the JDRF Center of Excellence in New England. The new center is comprised of a team of experts from institutions in New England including JAX’s Lenny Shultz, Ph.D.
The Churchill lab performed an integrative multi-omics analysis of 58 genetically diverse Collaborative Cross strains to identify regulators of protein phosphorylation.
glue solutions inc., a firm specializing in data science and visualization, grew out of a project to visualize astronomy data and is now working with JAX to do the same for genomics, providing ways to bring the genetic data to life.